Lincoln Pharmaceuticals Balance Sheet
- Market cap
- ₹1,127 crore
- P/E
- 22.5
- P/B
- 2.85
- ROE
- 14.5%
- Dividend yield
- 1.20%
- 52-week range
- ₹405.18 – ₹759.71
As of FY25, Lincoln Pharmaceuticals had total assets of ₹733 crore and borrowings of ₹135 crore, against shareholders' equity of ₹627 crore — a debt-to-equity ratio of 0.35.
Lincoln Pharmaceuticals balance sheet
As at each financial year end, newest first. H1 = half-year.
| Item | FY25 |
|---|---|
| Equity capital | 120 |
| Reserves | 507 |
| Borrowings | 135 |
| Other liabilities | 90.17 |
| Total liabilities | 733 |
| Fixed assets | 395 |
| Capital work in progress | 45 |
| Investments | 169 |
| Other assets | 169 |
| Total assets | 733 |
Balance sheet ratios
- Debt to equity
- 0.35
- Book value per share
- ₹197.46
Source: Company filings (consolidated), in ₹ crore. Data as of 9 October 2026. How this data is compiled.
Lincoln Pharmaceuticals balance sheet — frequently asked questions
What is the total debt of Lincoln Pharmaceuticals?
Lincoln Pharmaceuticals reported borrowings of ₹135 crore as of FY25.
What is Lincoln Pharmaceuticals' debt-to-equity ratio?
Based on the FY25 balance sheet, Lincoln Pharmaceuticals' debt-to-equity ratio is 0.35 — borrowings of ₹135 crore against equity capital and reserves of ₹627 crore.
What are Lincoln Pharmaceuticals' total assets?
Lincoln Pharmaceuticals' total assets were ₹733 crore as of FY25, including fixed assets of ₹395 crore and investments of ₹169 crore.
What is the book value per share of Lincoln Pharmaceuticals?
The book value per share of Lincoln Pharmaceuticals is ₹197.46, based on the latest reported balance sheet.
Same Data For Peers
Trade Lincoln Pharmaceuticals With ATS
Track LINCOLN live and place orders from the Pocket app or the Pocket Web terminal with an ATS trading and demat account.
Figures are for information only and are not investment advice or a recommendation to buy, sell or hold any security. Investments in securities are subject to market risks; read all related documents carefully before investing.